“…In addition to the definition of mutation sites in the synchronous multiple primary samples, we also classified mutated genes with various diseases, BPs, and MFs through cluster analysis. Notably, mutations in ALK and PTEN are concordant in a range of tumor types, including lung adenocarcinoma, endometrial cancer, colorectal cancer, and triple‐negative breast cancer [ 15 , 16 , 17 , 18 , 19 ]. Previously, a study examining clinically relevant mutations in 91 different malignancies also found mutation sites in anaplastic lymphoma kinase (ALK) and PTEN [ 20 ].…”